These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4267401)

  • 41. [Preliminary results of the therapeutic effectiveness in leukemia and malignant tumors in children of a new antineoplastic antibiotic: "daunomycin"].
    Massimo L; Fossati-Guglielmoni A; Fortuna E
    Arch Ital Patol Clin Tumori; 1967; 10(1):3-19. PubMed ID: 4878269
    [No Abstract]   [Full Text] [Related]  

  • 42. [Treatment of acute myeloid leukemia with daunomycin (38 cases)].
    D'auteuil P; Harel P
    Union Med Can; 1976 Feb; 105(2):205-10. PubMed ID: 1069395
    [No Abstract]   [Full Text] [Related]  

  • 43. [Side effect of rubomycin on the myocardium during treatment of acute leukemia in children].
    Vorob'ev AS; Alekseev NA
    Pediatriia; 1976 Aug; (8):39-40. PubMed ID: 1012810
    [No Abstract]   [Full Text] [Related]  

  • 44. Observations on toxicity and clinical trials with daunomycin.
    Serpick AA; Henderson ES
    Pathol Biol; 1967 Oct; 15(19):909-12. PubMed ID: 4967536
    [No Abstract]   [Full Text] [Related]  

  • 45. Preliminary evaluation of daunomycin in children with acute leukemia.
    Shore NA; Hartmann JR
    Pathol Biol; 1967 Oct; 15(19):939. PubMed ID: 4869769
    [No Abstract]   [Full Text] [Related]  

  • 46. Phase I clinical trial of orally administered 4-demethoxydaunorubicin (idarubicin) with pharmacokinetic and in vitro drug sensitivity testing in children with refractory leukemia.
    Pui CH; de Graaf SS; Dow LW; Rodman JH; Evans WE; Alpert BS; Murphy SB
    Cancer Res; 1988 Sep; 48(18):5348-52. PubMed ID: 3165708
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Daunorubicin (Cerubidine).
    Med Lett Drugs Ther; 1980 Apr; 22(8):34-5. PubMed ID: 6988689
    [No Abstract]   [Full Text] [Related]  

  • 48. [Sudden death in leukemic patients treated with doxorubicin].
    Lacasse Y; Bolduc P
    Can J Cardiol; 1992; 8(1):53-6. PubMed ID: 1617512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac toxicity of daunorubicin.
    Bonadonna G; Monfardini S
    Lancet; 1969 Apr; 1(7599):837. PubMed ID: 4180385
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of acute granulocytic leukemias with daunomycin].
    Eur J Cancer (1965); 1969 Sep; 5(4):339-42. PubMed ID: 5259625
    [No Abstract]   [Full Text] [Related]  

  • 51. [The effect of cytostatic therapy on hemodynamics (author's transl)].
    Schwingshackl H; Schwingshackl A; Dienstl F; Knapp E; Gmeiner R
    Med Klin; 1974 Feb; 69(7):298-303. PubMed ID: 4522909
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effects of adriamycin and daunomycin on cardiac functions].
    Tanaka T; Suzuki K; Ota M; Hiyoshi Y; Yoshioka F; Kato H
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2393-8. PubMed ID: 6639100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anthracycline induced cardiomyopathy: successful treatment with angiotensin converting enzyme inhibitors.
    Hauser M; Wilson N
    Eur J Pediatr; 2000 May; 159(5):389. PubMed ID: 10834529
    [No Abstract]   [Full Text] [Related]  

  • 54. Risk factors for development of daunorubicin cardiotoxicity.
    Von Hoff DD; Layard M
    Cancer Treat Rep; 1981; 65 Suppl 4():19-23. PubMed ID: 7049377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Trial treatment of acute leukemia and Hodgkin's disease with rubidomycin (or daunomycin) alone or in combination].
    Mathé G; Amiel JL; Hayat M; Schwarzenberg L; Schneider M; Cattan A; Schlumberger JR; Ceoara B
    Sem Hop; 1967 Jul; 43(32):2108-14. PubMed ID: 4292321
    [No Abstract]   [Full Text] [Related]  

  • 56. Nephrotic syndrome developed in a patient with acute promyelocytic leukemia treated with daunomycin.
    Morino N; Nojima Y; Mimura T; Hamasai K; Nakamoto T; Hirai H; Arai M; Matsuya S; Yazaki Y
    Nephron; 1995; 70(3):374-5. PubMed ID: 7477632
    [No Abstract]   [Full Text] [Related]  

  • 57. [Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia].
    Haruyama H; Shimazaki C; Nakanishi S; Hamami T; Nisio A; Isemura T; Katsume H; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):516-21. PubMed ID: 6964037
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Use of Adriamycin (NSC 123, 127, Farmitalia) in acute leukemias of childhood].
    Landbeck G; Götze-Bender C; Kurme A; Pauka B; Winkler K
    Monatsschr Kinderheilkd (1902); 1972 Apr; 120(4):146-8. PubMed ID: 4503949
    [No Abstract]   [Full Text] [Related]  

  • 59. A phase 1 and 2 trial of rubidazone in patients with acute leukemia.
    Benjamin RS; Keating MJ; McCredie KB; Bodey GP; Freireich EJ
    Cancer Res; 1977 Dec; 37(12):4623-8. PubMed ID: 270389
    [No Abstract]   [Full Text] [Related]  

  • 60. [Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy].
    Svojgrová M; Slechtová J; Hůla J
    Vnitr Lek; 1991 Feb; 37(2):151-9. PubMed ID: 2021075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.